| S. No. | INTERMEDIATE NAME | CAS NUMBER |
|---|---|---|
| ATORVASTATIN | ||
| 1.0 | Atorvastatin acetonide tert-butyl ester: tert-Butyl (4R,6R)-2-[6-[2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl] ethyl-2,2-dimethyl-1,3-dioxan-4-yl]acetate | 125971-95-1 |
| 2.0 | Diketone: 2-(2-(4-Fluorophenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxo-N-phenylpentanamide | 125971-96-2 |
| POSACONAZOLE | ||
| 3.0 | N'-((2S.3S)-2-(Benzyloxy)pentan-3-yl)formohydrazide oxalate | 1887197-42-3 |
| 4.0 | [(2S)-2-(Phenylmethoxy)2propylidene]hydrazine carboxaldehyde | 170985-84-9 |
| REPAGLINIDE | ||
| 5.0 | [3-Ethoxy-(4-ethoxycarbonyl)phenyl]acetic acid | 99469-99-5 |
| 6.0 | L(-)-N-Acetyl glutamic acid salt of S-(+)-3-methyl-1-(2-piperidino phenyl)-1-butyl amine Synonym: [(S)-1-(2-Piperidinophenyl)-3-methyl-1-butylamine N-acetyl-L-glutamic acid salt |
219921-94-5 |
| LEVOCETIRIZINE | ||
| 7.0 | (-)-4-Chlorobenzhydrylamine | 5267-39-0 |
| ZIPRASIDONE | ||
| 8.0 | 3-(1-Piperazinyl)-1,2-benzisothiozole hydrochloride | 87691-88-1 |
| 9.0 | 3-(1-Piperazinyl)-1,2-benzisothiazole | 87691-87-0 |
| 10.0 | 6-Chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one | 118307-04-3 |
| 11.0 | 6-Chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one | 118289-55-7 |
| TELMISARTAN | ||
| 12.0 | [2-[4'-(Bromomethyl)phenyl]benzoic acid, methyl ester Synonyms: (Bromomethyl)biphenylmethyl ester |
114772-38-2 |
| SERTRALINE | ||
| 13.0 | (R,S)-N-Methyl-4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenimine | 79560-20-6 |
| CANDESARTAN | ||
| 14.0 | Methyl-1-[(2-cyanobiphenyl-4-yl)methyl]-2-thoxybenzimidazole-7-carboxylate | 139481-44-0 |
| 15.0 | Methyl-2-ethoxy-1-[(2’-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl] benzimidazole-7-carboxylate | 139481-69-9 |
| 16.0 | 2-Ethoxy-1-[(2’-(1-triphenylmethyl)-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid | 139481-59-7 |
| - | 1-Chloroethylcyclohexylcarbonate | 99464-83-2 |
| VARDENAFIL | ||
| 17.0 | 2-(2-Ethoxyphenyl)-5-methyl-7-propylimidazole[5,1-F][1,2,4] triazin-4(3H)-one | 224789-21-3 |
| 18.0 | 2-Ethoxy benzamidine hydrochloride | 18637-00-8 |
| AZILSARTAN INTERMEDIATE | ||
| 19.0 | 2-Ethoxy-1-((2’-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl) biphenyl-4-yl) methyl)-1H-benzo[d]imidazole-7-carboxylic acid | 147403-52-9 |
| DOLUTEGRAVIR INTERMEDIATE | ||
| 20.0 | 1-(2,2-Dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-carboxylic acid | 1335210-23-5 |
| FLUPIRTINE | ||
| 21.0 | 2-Amino-6-chloro-3-nitropyridine | 27048-04-0 |
| LABETALOL | ||
| 22.0 | 5-Acetylsalicylamide | 40187-51-7 |
| ELUGLUSTAT | ||
| 23.0 | 1,4-Benzodioxane | 493-09-4 |
| RALOXIFENE | ||
| 24.0 | 4-(2-Piperidinoethoxy)benzoic acid hydrochloride | 84449-80-9 |
| LAMOTRIGINE | ||
| 25.0 | 2,3-Dichlorobenzoyl cyanide* | 77668-42-9 |
Ready for Commercialization - The following advanced intermediates and API are in our late-stage pipeline and are primed for scale-up and commercial partnerships.
| S. No. | NAME | CAS NUMBER |
|---|---|---|
| API | ||
| 26.0 | Atorvastatin calcium trihydrate [API] | 344423-98-9 |
| LAMOTRIGINE | ||
| 27.0 | 2-(2,3-Dichlorphenyl)-2-(guanidinylimino) acetonitrile* | 84689-20-3 |
| POSACONAZOLE | ||
| 28.0 | 1-((2S,3S)-2-(Benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl) piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5-(4H)-one* | 184177-83-1 |
| SERTRALINE | ||
| 29.0 | Cis-N-Methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine hydrochloride Synonym: Racemic sertraline hydrochloride |
79617-89-3 |
| NINTEDANIB | ||
| 30.0 | 2-Oxo-1,3-dihydroindole-6-carboxylic acid methyl ester* | 14192-26-8 |
| PALBOCICLIB/RIBOCICILB | ||
| 31.0 | tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate* | 571188-59-5 |
| PALBOCICLIB | ||
| 32.0 | 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d] pyrimidin-7(8H)-one* | 1016636-76-2 |
| OLMESARTAN MEDOXOMIL | ||
| 33.0 | Trityl Olmesartan medoxomil* | 144690-92-6 |
| MAVACAMTEN | ||
| 34.0 | 1-Isopropylpyrimidine-2,4,6(1H,3H,5H)-trione* Synonyms: Isopropyl barbituric acid; |
69998-14-7 |
| RIVAROXABAN | ||
| 35.0 | 4-[4-(5S)-5-Phthalimidomethyl-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone * | 446292-08-6 |
| OLANZAPINE | ||
| 36.0 | 4-[Amino-2-methyl-10H-thiene[2,3-b][1,5]benzodiazepine hydrochloride * | 138564-60-0 |
| EZETIMIBE | ||
| 37.0 | ((S)-1-(4-Fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl) pentane-1,5-dione * | 189028-93-1 |
NOTE:
* Process as per Base Patent (Innovator).
* The Products will not be offered to the Countries where valid Patents Exist.